Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LAVA

LAVA Therapeutics (LAVA) Stock Price, News & Analysis

LAVA Therapeutics logo

About LAVA Therapeutics Stock (NASDAQ:LAVA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Magma Design Automation, Inc. (Magma) provides electronic design automation (EDA) software products and related services. Its software enables chip designers to reduce the time it takes to design and produce integrated circuits used in the communications, computing, consumer electronics, networking and semiconductor industries. Its flagship products consist of a digital integrated solution for the chip development cycle, from initial design through physical implementation. Magma's flagship Talus family of products, its Tekton static timing analyzer and QCP extractor and, its Quartz family of sign-off and verification tools combine into one integrated chip design and verification flow, from what has been separate logic design, physical design, and analysis and sign-off processes. Its Titan platform for custom integrated chip design provides an integrated chip-finishing solution for mixed-signal designs. In February 2012, Synopsys, Inc. acquired the Company.

Receive LAVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

LAVA Stock News Headlines

Lava Therapeutics expects $1M of expenses related to restructuring plan
JMP Securities Sticks to Its Hold Rating for LAVA Therapeutics (LVTX)
New Rule Hits in July — The Smart Money Already Moved
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
Lava Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
LAVA Announces Evaluation of Strategic Options
See More Headlines

LAVA Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that LAVA Therapeutics investors own include Inovio Pharmaceuticals (INO), Sprott Physical Silver Trust (PSLV), MAG Silver (MAG).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:LAVA
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:LAVA) was last updated on 6/29/2025 by MarketBeat.com Staff
From Our Partners